Post-menopausal metrorrhagia. use of danazol in endometrial hyperplasia
Baldoni, A.; Donati Sarti, C.; Affronti, G.; Liotta, L.; Martinoli, V.; Cosco, A.G.; Cardinali, L.; Pomili, G.; Giannone, E.
Minerva Ginecologica 41(12): 603-607
1989
ISSN/ISBN: 0026-4784 PMID: 2626205 Document Number: 339021
The Authors, after a careful examination of the literature on endometrial hyperplasias, review the results of a preliminary study on 15 patients affected with postmenopausal metrorrhagia, cured by Danazol (200 mg/die) through 90 consecutive days. Also recognizing the best tolerance to the drug and the low incidence of the side effects, they think the results obtained by Danazol need further confirmation by more protracted controls.